Published: Guidance, quality standards and advice
Showing 1 to 7 of 7
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen | TA515 | ||
| Cabozantinib for treating medullary thyroid cancer | TA516 | ||
| Brodalumab for treating moderate to severe plaque psoriasis | TA511 | ||
| Tivozanib for treating advanced renal cell carcinoma | TA512 | ||
| Obinutuzumab for untreated advanced follicular lymphoma | TA513 | ||
| Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee | TA508 | ||
| Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer | TA509 |